DIA Biosimilars 2013

Almac

Almac, DSM sign collaboration agreement in biocatalysis

Wednesday, October 10, 2012 12:24 PM

Global service provider Almac has signed a collaboration agreement with DSM Pharmaceutical Products, the custom manufacturing and technology business of Royal DSM, in the field of biocatalysis to provide sustainable manufacturing services to the pharmaceutical industry.

More... »

Cenduit: Now with Patient Reminders

Almac concludes commercial API manufacturing facility expansion plans

Wednesday, October 10, 2012 10:14 AM

In response to client requirements, global service provider Almac’s expansion of their API manufacturing facility at its European headquarters in Craigavon, U.K. is near completion, and will be operational by the end of the year. 

More... »

CRF Health – eCOA Forum

Almac expands U.K. capacity with the acquisition of blistering tech

Wednesday, October 3, 2012 03:24 PM

Almac, a global service provider, has expanded its MHRA/FDA approved U.K. commercial packaging facility with the acquisition of a state-of-the-art Noack N 623 blister packaging line from Romaco.

More... »

Successful MHRA inspection of Almac’s clinical services U.K. facility

Wednesday, September 26, 2012 11:18 AM

Global service provider Almac passed a successful inspection of its clinical services operations located in Craigavon by the U.K. Medicines and Healthcare products Regulatory Agency (MHRA).

More... »

Almac launches next generation sequencing service for personalized medicine

Tuesday, August 21, 2012 09:10 AM

Global service provider Almac is launching a next generation sequencing (NGS) service to further expand its range of solutions supporting the development of personalized medicine.

More... »

Almac enhances service offering in refrigerated storage

Wednesday, August 8, 2012 11:38 AM

Almac, a global service provider based in Ireland, has further enhanced its service offering with the completed expansion of refrigerated (2-8°C) storage and newly developed refrigerated labelling facilities at its U.K. site. 

More... »

Almac launches mobile web site

Monday, July 2, 2012 12:25 PM

Almac launched a mobile optimized version of its web site, enabling biotech and pharma clients and prospective customers to access Almac’s content while out of the office with only a smartphone in hand.

More... »

Almac, VTU Technology to offer joint services

Monday, June 11, 2012 10:17 AM

Worldwide CRO Almac and European CRO VTU Technology have formed a collaboration to offer joint services for the expression of recombinant proteins with site-specific modification and labelling, such as PEGylation for half-life extension of proteins.

More... »

Almac rewarded for excellence in technology

Monday, April 30, 2012 04:33 PM

Service provider Almac has been recognized for its technological developments, scooping a top award at the recent Belfast Telegraph Northern Ireland Business Awards 2012, in association with British Midland International (BMI).

More... »

Almac adds aXcess to suite of services

Monday, March 12, 2012 02:02 PM

Contract service provider Almac is relaunching an enhanced version of its web-based randomization system WebEZ under the new name aXcess. 

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs